ATE457353T1 - Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon - Google Patents

Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon

Info

Publication number
ATE457353T1
ATE457353T1 AT04797116T AT04797116T ATE457353T1 AT E457353 T1 ATE457353 T1 AT E457353T1 AT 04797116 T AT04797116 T AT 04797116T AT 04797116 T AT04797116 T AT 04797116T AT E457353 T1 ATE457353 T1 AT E457353T1
Authority
AT
Austria
Prior art keywords
virus
interleukin
latent phase
vii
homologue
Prior art date
Application number
AT04797116T
Other languages
English (en)
Inventor
Barry Slobedman
Allison Abendroth
Christina Jenkins
Original Assignee
Univ Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003906613A external-priority patent/AU2003906613A0/en
Application filed by Univ Sydney filed Critical Univ Sydney
Application granted granted Critical
Publication of ATE457353T1 publication Critical patent/ATE457353T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Transplantation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT04797116T 2003-11-28 2004-11-26 Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon ATE457353T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003906613A AU2003906613A0 (en) 2003-11-28 Interleukin-10 Homologue and Uses Thereof
PCT/AU2004/001675 WO2005052159A1 (en) 2003-11-28 2004-11-26 Latent phase viral interleukin-10-(vii-10) and uses thereof

Publications (1)

Publication Number Publication Date
ATE457353T1 true ATE457353T1 (de) 2010-02-15

Family

ID=34624267

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04797116T ATE457353T1 (de) 2003-11-28 2004-11-26 Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon

Country Status (6)

Country Link
US (2) US8133700B2 (de)
EP (1) EP1702068B1 (de)
AT (1) ATE457353T1 (de)
AU (1) AU2004293499B2 (de)
DE (1) DE602004025509D1 (de)
WO (1) WO2005052159A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2295450B1 (de) 2000-09-29 2015-01-28 Merck Sharp & Dohme Corp. Pegyliertes interleukin 10
ES2655364T3 (es) 2008-12-17 2018-02-19 Merck Sharp & Dohme Corp. Producción de IL-10 mono- y dipegilada y sus usos
MX2015014438A (es) 2013-04-18 2016-05-18 Armo Biosciences Inc Metodos de uso de interleucina-10 para tratar enfermedades y trastornos.
EP3010527B1 (de) 2013-06-17 2018-08-08 Armo Biosciences, Inc. Verfahren zur beurteilung der proteinidentität und -stabilität
CN105658232A (zh) 2013-08-30 2016-06-08 阿尔莫生物科技股份有限公司 使用白细胞介素-10治疗疾病和病症的方法
EP3063274A4 (de) * 2013-10-29 2017-04-05 The University Of Sydney Cmv-immunerregende zusammensetzung
CN120242030A (zh) 2013-11-11 2025-07-04 阿尔莫生物科技股份有限公司 将白细胞介素-10用于治疗疾病和病症的方法
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
WO2016060996A2 (en) 2014-10-14 2016-04-21 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
AU2015336101A1 (en) 2014-10-22 2017-04-20 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2016168741A2 (en) * 2015-04-16 2016-10-20 Spencer Juliet V Detection of human cytomegalovirus
US20160361415A1 (en) 2015-05-28 2016-12-15 Armo Biosciences, Inc. Methods of Using Interleukin-10 for Treating Diseases and Disorders
KR20180038553A (ko) 2015-08-25 2018-04-16 아르모 바이오사이언시스 인코포레이티드 질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법
CN114349858B (zh) * 2022-01-26 2022-07-01 优睿赛思(武汉)生物科技有限公司 抗人白介素-10高亲和力兔单克隆抗体及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7346100A (en) * 1999-09-02 2001-03-26 University Of Medicine And Dentistry Of New Jersey Cytomegalovirus-encoded il-10 homolog
US6692954B1 (en) 2000-11-03 2004-02-17 The Scripps Research Institute Generation of human cytomegalovirus yeast artificial chromosome recombinants
CA2442089A1 (en) 2001-03-27 2002-10-03 Dendreon San Diego Llc Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
US7361460B2 (en) * 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases
US7407744B2 (en) * 2003-07-25 2008-08-05 The Regents Of The University Of California Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors

Also Published As

Publication number Publication date
US8133700B2 (en) 2012-03-13
WO2005052159A1 (en) 2005-06-09
US20120134957A1 (en) 2012-05-31
DE602004025509D1 (de) 2010-03-25
EP1702068A1 (de) 2006-09-20
AU2004293499B2 (en) 2009-11-26
EP1702068A4 (de) 2007-07-11
AU2004293499A1 (en) 2005-06-09
US20090214463A1 (en) 2009-08-27
WO2005052159A8 (en) 2005-08-18
EP1702068B1 (de) 2010-02-10

Similar Documents

Publication Publication Date Title
ATE457353T1 (de) Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon
ATE376559T1 (de) Methoden der verhinderung und behandlung der alzheimer'schen krankheit
ATE364698T1 (de) Neues, physiologisch aktives peptid und dessen verwendung
DE69536039D1 (de) Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
EA200400023A1 (ru) Ингибиторы вич-протеазы, содержащие их композиции, их фармацевтическое использование и материалы для их синтеза
CL2003001743A1 (es) Compuestos derivados de leucinamida, inhibidores de la cisteina proteasa; composicion farmaceutica; procedimiento de preparacion de la composicion farmaceutica; y su uso en el tratamiento de la osteoporosis, enfermedad de paget's, peridontal, perdida
BRPI0411363A (pt) seqüências de ácidos nucléicos codificando e composições compreendendo peptìdeo sinal ige e/ou il-15 e processos para uso das mesmas
WO2004085633A8 (en) A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof
DK1007685T3 (da) Overfladeeksponerede proteiner fra chlamydia pneumoniae
ATE397624T1 (de) Cystine-knot fold protein
EA200501711A1 (ru) Семейство секретируемых белков
DE69735039D1 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
DE60028407D1 (de) Proteine und für diese kodierende dna
HK1045712A1 (zh) Fimh粘附素基疫苗
DE60124523D1 (de) Zusammensetzung einer Parvovirus VP1-Proteinvariante und eines arvovirus NS1-Proteins zur Induktion von Zytolyse
HUP0302416A2 (hu) Tisztított hepatitis-C vírusmembrán-proteinek diagnosztikai és terápiás célú alkalmazása
ATE267397T1 (de) Reagenz zum nachweis und weiterverfolgen von virusinfektionen
MXPA05009954A (es) Familia de proteinas secretadas.
ATE411812T1 (de) Peptide zur behandlung von infektionen mit dem herpes-virus
De Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and Enteroviruses
IL169256A (en) Polypeptide having metalloprotease activity, nucleic acid encoding it and pharmaceutical composition comprising it
IL118103A (en) Composition of thymus factor protein comprising a lysine-rich histone factor capable of precipitating beta-, alpha1-, alpha2-macroglobulins of a healthy mammal
WO2003095482A3 (fr) Nouveaux peptides cycliques, leur utilisation comme agents anti-microbiens.
NO20052525D0 (no) Spleisevariant av humant hypofyseveksthormon
NO20053512L (no) IL-8-liknende proteiner

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties